Advertisement

Topics

Haematological cancer: Staging and restaging patients with lymphoma — a better approach?

17:24 EDT 20 Jun 2017 | Nature Publishing

Response criteria for disease assessment have important therapeutic and prognostic implications in clinical trials and in routine clinical practice. The Lugano classification has been used widely for evaluation of the response of patients with lymphoma to treatment, although the alternative Response Evaluation Criteria In Lymphoma 2017 (RECIL 2017) classification was recently proposed; these criteria are compared herein.

Original Article: Haematological cancer: Staging and restaging patients with lymphoma — a better approach?

NEXT ARTICLE

More From BioPortfolio on "Haematological cancer: Staging and restaging patients with lymphoma — a better approach?"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Clinical Approvals
Clinical trials are a set of procedures in medical research conducted to allow safety (or more specifically, information about adverse drug reactions and adverse effects of other treatments) and efficacy data to be collected for health interventions (e.g...